Donita C. Brady, PhD
Donita C. Brady, PhD, the Harrison McCrea Dickson, MD, and Clifford C. Baker, MD, Presidential Professor in Cancer Biology, has been named to The Pew Charitable Trusts’ 2023 class of Innovation Fund investigators. Brady, a 2016 Pew biomedical scholar, will team up with Kivanç Birsoy, PhD, of The Rockefeller University, to identify cell components that regulate—or respond to—transition metals, key dietary nutrients that maintain health in humans and other organisms.
Yanxiang Deng, PhD
Yanxiang Deng, PhD, an assistant professor of Pathology and Laboratory Medicine, has been awarded a 2023 Packard Fellowship for Science and Engineering. As a member of the 35th Anniversary class of fellows, Deng will receive $875,000 over five years to pursue his research, which focuses on developing new tools at the intersection of microchip, microscopy, and genomics to study tissue complexity.
Oluwadamilola “Lola” Fayanju, MD, MA, MPHS
Oluwadamilola “Lola” Fayanju, MD, MA, MPHS, the Helen O. Dickens Presidential Associate Professor and chief of the Breast Surgery Division, has been named a Breast Cancer Research Foundation (BCRF) Investigator. She was awarded $225,000 for her research to identify and address factors that contribute to racial disparities in breast cancer outcomes that add to treatment delays or decrease treatment adherence.
Carl June, MD
Carl June, MD, the Richard W. Vague Professor in Immunotherapy, has been named a recipient of the 2023 “Lombardy is Research” Prize for the development of immunotherapy with natural and genetically modified cells. The award recognizes significant research, discoveries, and socially impactful inventions in the field of life science with a specific focus on "Innovative Models of Care, Therapy, and Prevention.” Winners share a €1,000,000 prize.
Roy Rosin, chief innovation officer, has been selected for Becker’s Healthcare’s list of Hospital and Health System Chief Innovation Officers to Know in 2023. In this role since 2012, Rosin is charged with identifying, shaping, and implementing improvements in patient health outcomes and patient experience while also testing for potential new revenue streams.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.